M&A Deal Summary

Renovaro Biosciences Acquires Cyclomics

On April 24, 2024, Renovaro Biosciences acquired life science company Cyclomics

Acquisition Highlights
  • This is Renovaro Biosciences’ 2nd transaction in the Life Science sector.
  • This is Renovaro Biosciences’ 2nd transaction in the Netherlands.

M&A Deal Summary
Date 2024-04-24
Target Cyclomics
Sector Life Science
Buyer(s) Renovaro Biosciences
Deal Type Add-on Acquisition

Target

Cyclomics

Utrecht, Netherlands
website
Cyclomics is a 4th generation multi-omics molecular biology company that offers accurate measurement of cancer recurrence using liquid biopsies. Cyclomics was formed in 2018 and is based in Utrecht, Netherlands.

Search 193,092 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Renovaro Biosciences

Los Angeles, California, United States

website

Category Company
Sector Life Science
DESCRIPTION

Renovaro Biosciences has developed advanced cell, gene and immunotherapy platforms designed to renew the body's natural tumor-fighting capabilities against cancer and infectious diseases. Renovaro Biosciences is based in Los Angeles, California.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 2 of 2
Country (Netherlands) 2 of 2
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-09-29 GEDi Cube

Amsterdam, Netherlands

GEDi Cube is an AI medical technology company. GEDi Cube is pioneering a multi-modal approach for the early detection of cancer and its recurrence involving blood biopsies, imaging, and multiomic analysis. GEDi Cube is based in Amsterdam, the Netherlands.

Buy -
Mergr

Product

Company

Legal